Objective: This study investigated the incidence of clozapine-associated ur
inary incontinence (UI) in schizophrenic patients, the percentage of these
patients with persistent urinary incontinence (PUI), and the possible facto
rs affecting the occurrence of UI.
Method: A total of 61 Chinese in-patients with schizophrenia (according to
DSM-IV) treated with clozapine for more than 3 months were assessed retrosp
ectively for the occurrence of UI. Patients who still had UI at the time of
assessment were classified as having PUI. Patients whose UI had resolved a
t the time of assessment were classified as having self-limited urinary inc
ontinence (SUI). We compared the characteristics of UT and non-UT cases and
of PUI and SUI cases.
Results: The results showed that urinary incontinence developed at some tim
e in 27 of 61 patients (44.3%), and that it was persistent in 15 of 61 pati
ents (25%). There were no statistically significant differences in age, sex
, clozapine dose, duration of clozapine use, duration of index admission, d
uration of illness, age at onset of schizophrenia, or concurrent treatment
with other psychiatric medications between the UI and non-UI groups and bet
ween the PUI and SUI groups.
Conclusion: Clozapine-associated urinary incontinence may be persistent in
some patients, and it should be cautiously monitored in every patient takin
g clozapine.